Risk factors for meticillin resistance and outcome of Staphylococcus aureus bloodstream infection in a Belgian university hospital

被引:34
作者
Libert, M. [1 ]
Elkholti, M. [1 ]
Massaut, J. [1 ]
Karmali, R. [1 ]
Mascart, G. [1 ]
Cherifi, S. [1 ]
机构
[1] Brugmann Univ Hosp, B-1020 Brussels, Belgium
关键词
Staphylococcus aureus; bloodstream infection; risk factors for meticillin resistance; mortality;
D O I
10.1016/j.jhin.2007.08.021
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The aim of this study was to identify institution-specific risk factors for meticillin resistance in Staphylococcus aureus bloodstream infection (BSI) and to evaluate the impact of meticillin resistance on mortality. A total of 154 episodes of S. aureus BSI were identified between 1 January 2002 and 31 December 2004: 66 meticillin-resistant S. aureus (MRSA) BSI and 88 meticillin-susceptible S. aureus (MSSA) BSI. Seventy-eight episodes (51%) were considered to be community-acquired and 76 (49%) as nosocomial. Risk factors associated with MRSA BSI included not living at home (P = 0.001), prior antibiotic exposure (P = 0.002), insulin-requiring diabetes (P = 0.028) and nosocomial BSI (P = 0.031), especially more than 12.5 days after admission. There was an association between BSI-related mortality and the following variables: septic shock (P < 0.001), endocarditis (P = 0.002) and MRSA BSI (P = 0.021). In conclusion, S. aureus BSI is a serious condition, especially when septic shock or endocarditis occurs, and is aggravated by meticillin resistance. We advise glycopeptides as empirical therapy for patients not arriving from home, those exposed to antibiotics, and those with insulin-requiring diabetes and/or nosocomial BSI. (c) 2007 The Hospital Infection Society. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:17 / 24
页数:8
相关论文
共 31 条
[1]  
[Anonymous], 1996, INFECT CONTROL APPL
[2]  
Bannerman TL., 2003, MANUAL CLIN MICROBIO, P384
[3]   A prospective study of risk factors for diabetic foot ulcer - The Seattle diabetic foot study [J].
Boyko, EJ ;
Ahroni, JH ;
Stensel, V ;
Forsberg, RC ;
Davignon, DR ;
Smith, DG .
DIABETES CARE, 1999, 22 (07) :1036-1042
[4]   A prospective multicenter study of Staphylococcus aureus bacteremia -: Incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance [J].
Chang, FY ;
MacDonald, BB ;
Peacock, JE ;
Musher, DM ;
Triplett, P ;
Mylotte, JM ;
O'Donnell, A ;
Wagener, MM ;
Yu, VL .
MEDICINE, 2003, 82 (05) :322-332
[5]  
Conterno LO, 1998, INFECT CONT HOSP EP, V19, P32
[6]   Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia:: A meta-analysis [J].
Cosgrove, SE ;
Sakoulas, G ;
Perencevich, EN ;
Schwaber, MJ ;
Karchmer, AW ;
Carmeli, Y .
CLINICAL INFECTIOUS DISEASES, 2003, 36 (01) :53-59
[7]   The impact of methicillin-resistance in Staphylococcus aureus bacteremia on patient outcomes:: Mortality, length of stay, and hospital charges [J].
Cosgrove, SE ;
Qi, YL ;
Kaye, KS ;
Harbarth, S ;
Karchmer, AW ;
Carmeli, Y .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2005, 26 (02) :166-174
[8]   Methicillin-resistant Staphylococcus aureus in the diabetic foot clinic:: a worsening problem [J].
Dang, CN ;
Prasad, YDM ;
Boulton, AJM ;
Jude, EB .
DIABETIC MEDICINE, 2003, 20 (02) :159-161
[9]   Epidemiology, clinical and laboratory characteristics of Staphylococcus aureus bacteraemia in a university hospital in UK [J].
Das, I. ;
O'Connell, N. ;
Lambert, P. .
JOURNAL OF HOSPITAL INFECTION, 2007, 65 (02) :117-123
[10]   National surveillance of methicillin-resistant Staphylococcus aureus in Belgian hospitals indicates rapid diversification of epidemic clones [J].
Denis, O ;
Deplano, A ;
Nonhoff, C ;
De Ryck, R ;
de Mendonça, R ;
Rottiers, S ;
Vanhoof, R ;
Struelens, MJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (09) :3625-3629